Cargando…
Development of Potent Inhibitors of Receptor Tyrosine Kinases by Ligand-Based Drug Design and Target-Biased Phenotypic Screening
[Image: see text] Pyrazolopyrimidines with potent antiproliferative properties were developed by an adaptive strategy that applies ligand-based design and phenotypic screening iteratively and is informed by biochemical assays. To drive development toward specific oncopathways, compounds were tested...
Autores principales: | Myers, Samuel H., Temps, Carolin, Houston, Douglas R., Brunton, Valerie G., Unciti-Broceta, Asier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851644/ https://www.ncbi.nlm.nih.gov/pubmed/29466002 http://dx.doi.org/10.1021/acs.jmedchem.7b01605 |
Ejemplares similares
-
Synthesis and Characterization
of a Click-Assembled
18-Atom Macrocycle That Displays Selective AXL Kinase Inhibitory Activity
por: Cruz-López, Olga, et al.
Publicado: (2019) -
Pyrazolopyrimide library screening in glioma cells discovers highly potent antiproliferative leads that target the PI3K/mTOR pathway
por: Valero, Teresa, et al.
Publicado: (2020) -
Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
por: Beetham, Henry, et al.
Publicado: (2022) -
Rapid Discovery
and Structure–Activity Relationships
of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth
via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase
por: Fraser, Craig, et al.
Publicado: (2016) -
Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold
por: Baillache, Daniel J., et al.
Publicado: (2020)